Avon's Breast Cancer Crusade to Offer 'Pink Ribbon' Pens

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 9
Volume 4
Issue 9

NEW YORK--Avon's Breast Cancer Awareness Crusade, which has raised $10 million through the sales of its $2 pink ribbon pin, has now introduced a pink-enameled ballpoint pen. The new pen, which bears the ribbon motif on its clip, will be available in October, 1995, at a cost of $3.

NEW YORK--Avon's Breast Cancer Awareness Crusade, which has raised$10 million through the sales of its $2 pink ribbon pin, has nowintroduced a pink-enameled ballpoint pen. The new pen, which bearsthe ribbon motif on its clip, will be available in October, 1995,at a cost of $3.

The pink ribbon has been selected by the breast cancer communityas the international symbol of hope and support for those affectedby breast cancer.

Proceeds from pen sales, as with ongoing sales of the pink ribbonpin, will go toward supporting community-based programs acrossthe country. These programs are dedicated to increasing awarenessof breast cancer and improving access to early detection services,especially for lower income, minority, and older women, and otherswho are medically underserved.

Woman-to-Woman Effort

Avon's Breast Cancer Awareness crusade has been working sinceOctober, 1993, to educate women about breast health. The crusadehas funded more than 125 community programs across the UnitedStates. In addition, Avon representatives have distributed 32million educational brochures in a woman-to-woman outreach effort.

Early on, Avon developed an innovative public/private/nonprofitpartnership with the YWCA of the USA, Centers for Disease Controland Prevention (CDC), National Alliance of Breast Cancer Organizations(NABCO), and National Cancer Institute, with the goal of improvingwomen's access to breast cancer services.

For information about the crusade and how to purchase the pinkribbon pen, call 1-800-FOR-AVON for the name of a neighborhoodAvon representative.

Related Videos
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey K. Anders, MD, an expert on breast cancer
A panel of 4 experts on breast cancer seated at a long table
A panel of 4 experts on breast cancer seated at a long table